The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
about
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung CancerA monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma.The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.The Predictive Role of the Neutrophil/Lymphocyte Ratio in Survival with Multiple Myeloma: A Single Center Experience.CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission.Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphomaEvaluation of the modified Glasgow Prognostic Score to predict outcome in dogs with newly diagnosed lymphoma.Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.White Blood Cell and Granulocyte Counts Are Independent Predictive Factors for Prognosis of Advanced Pancreatic Caner.Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis
P2860
Q33877471-443E53EB-20DF-4BD2-ACBC-69ADE0F84F2EQ33913878-7881BBAA-CFDE-473F-AE63-A9FE28B8974AQ35739550-11B475AC-BD39-4D04-88F1-42E77740E7D1Q36034748-0E62CFB1-1795-4CA6-984C-55028F027B1EQ36151154-F61DD570-B97E-4E04-A9C5-258979EB1519Q36186701-8A77DB95-8FBF-41AE-95DD-063366EBA343Q37588227-38A11E4C-A2BD-4B5E-9BC1-B0729E0A7D58Q38376847-60761F65-1B42-4D9E-ABBC-573827197266Q38980174-2654CC14-3E04-4C8D-852C-53B435E43E57Q39239606-A685D830-B170-4171-A5CA-FB392C5B9C06Q39423479-8EFBEB3A-D841-4E09-B860-420DE753DA30Q39513560-0ACE7449-0FFA-40C6-8FAE-46B6EA3B82C8Q39720114-1FBFA1ED-65DD-46AA-BEAE-855A60576439Q40000916-6F51FC06-3678-4908-B3B5-10C741FE5713Q40235024-C4E31468-F895-4505-BFF4-3058AE25FAE1Q40496418-5FCDF751-1D19-4B41-AAD2-D4F8C0D995C6Q40569572-73CA3680-8889-4ED8-81F1-AE1D38C04B17Q41162196-ADC2735E-DEF5-4F73-AA16-7EBD278C7DBBQ41471302-FB02C0A5-33BC-46AB-A8A1-1EB71E5FF034Q46424382-807FCF87-F13A-4785-9A37-CAD07075A790Q47098146-2FF7D723-AF34-4602-B562-6F2424682E48Q47151590-D99EA6F9-4943-4989-BCEF-4DCC74204CAFQ49085795-5144FA84-E74E-4695-8165-F5ACF4855762Q50545382-DE6226C9-4376-4F49-A934-B85226F0DD1FQ53620039-36F96570-ACC3-4E7D-85E6-9E771EEF0FDBQ55381575-5ACD52FE-C269-48CB-B97A-659EE9599AE9Q58724543-FC29FB12-D5EF-4C71-BC6F-7C03318D4838
P2860
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@en
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@nl
type
label
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@en
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@nl
prefLabel
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@en
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1476
The derived neutrophil to lymp ...... diffuse large B-cell lymphoma.
@en
P2093
C Beham-Schmid
P Neumeister
T Stojakovic
P2860
P2888
P304
P356
10.1038/BJC.2013.763
P407
P577
2013-12-19T00:00:00Z